Lonza Group (OTCMKTS:LZAGY) Downgraded by Zacks Research to "Hold"

Key Points

• Lonza Group was downgraded by Zacks Research from a "strong-buy" rating to a "hold" rating, impacting the outlook for the company's stock.
• The company's stock opened at $67.88 and has fluctuated between a one-year low of $55.57 and a high of $73.29.
• Lonza Group AG operates across various segments including Biologics, Small Molecules, and Cell & Gene, serving multiple international markets.

Lonza Group (OTCMKTS:LZAGY - Get Free Report) was downgraded by equities research analysts at Zacks Research from a "strong-buy" rating to a "hold" rating in a research note issued on Monday,Zacks.com reports.

Lonza Group Stock Performance

Lonza Group stock opened at $67.88 on Monday. The business has a 50 day simple moving average of $69.96 and a 200 day simple moving average of $68.22. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.04 and a current ratio of 1.52. Lonza Group has a one year low of $55.57 and a one year high of $73.29.

About Lonza Group

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.